Protenus Granted New Patent for Drug Diversion Surveillance Technology

Technology
Written By VS BRANDS

Protenus further expands the patent portfolio covering various techniques for detecting anomalous drug dispensing events.

Protenus logo

BALTIMORE, May 24, 2023 (VSNewsNetwork.com) - Protenus, a leading healthcare compliance analytics platform provider, has been granted a new patent for its drug diversion surveillance technology. The patent, titled "Methods and Systems for Analyzing Accessing of Drug Dispensing Systems," expands Protenus' portfolio of techniques for detecting anomalous drug dispensing events. The technology utilizes artificial intelligence and advanced analytics to audit medication use transactions, reducing the risk to healthcare organizations and patients. Protenus now holds multiple U.S. patents covering patient privacy monitoring and drug diversion surveillance, with additional patent applications pending. For licensing inquiries, contact Protenus General Counsel Amy Much at amy.much@protenus.com.

Learn more at Protenus.com and follow us on Twitter @Protenus. 

Source: Protenus, Inc. via Newswire

VS BRANDS https://linktr.ee/vsbrands
Previous

Mental Health Horror Film 'The Empty Space' by Andrew Jara to Release on VOD and DVD/Blu-Ray May 30th
Next

Apex Site Solutions Wins National U.S. Small Business Award for Business of the Year